Blacksmith Brands, Inc., in consultation with the U.S. Food and Drug Administration, is voluntarily recalling all lots of four children’s products in the PediaCare line. These products are sold exclusively in the United States.

Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today it is voluntarily expanding its March 31, 2010, recall of Propofol Injectable Emulsion 1% and Liposyn™ (Intravenous Fat Emulsion) products which include Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, and Liposyn III 30% to the consumer or user level. Hospira is conducting the recall because some of the containers may contain particulate matter.